Welcome to our dedicated page for Scotts Miracle Gr SEC filings (Ticker: SMG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Scotts Miracle-Gro Company (NYSE: SMG) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its operations, governance and financial condition. As an Ohio‑incorporated issuer with common shares listed on the New York Stock Exchange, ScottsMiracle-Gro uses periodic reports and current reports to describe its branded consumer lawn and garden business, indoor and hydroponic growing operations and related financing arrangements.
On this page, you can review core filings such as the annual report on Form 10‑K and quarterly reports on Form 10‑Q, which include segment information for U.S. Consumer, Hawthorne and Other, along with discussions of risk factors, liquidity, capital resources and segment performance. These filings also elaborate on topics referenced in company news releases, such as gross margin trends, leverage, free cash flow and the role of credit facilities and receivables programs in the capital structure.
Current reports on Form 8‑K provide more targeted updates. Recent 8‑K filings describe a Seventh Amended and Restated Credit Agreement establishing senior secured loan facilities, amendments to a master receivables purchase agreement, results of operations for specific quarters and changes to the board of directors and equity award documentation. These filings outline key terms such as leverage and interest coverage covenants, security packages and the use of proceeds for working capital and general corporate purposes.
Definitive proxy statements on Schedule 14A offer detail on corporate governance and executive compensation. ScottsMiracle-Gro’s proxy materials cover board composition, committee responsibilities, director independence, say‑on‑pay proposals, long‑term incentive plan terms, stock ownership guidelines and severance and change‑in‑control arrangements.
This filings page combines real‑time access to new EDGAR submissions with AI‑generated summaries that explain the structure and implications of each document. Users can quickly identify items such as 10‑K and 10‑Q reports, 8‑K current reports, proxy statements and exhibits related to credit agreements or incentive plans, and use the summaries to focus on the sections most relevant to their analysis of SMG.
Miaritis Nick reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Nick Miaritis reported an equity-related award rather than an open-market trade. He received 64 dividend equivalent rights on March 6, 2026, at a price of $0.00 per right, bringing his directly held dividend equivalent rights to 194.
The filing explains these dividend equivalent rights accrue on deferred or restricted stock units and become exercisable in step with those underlying awards. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, aligning the director’s compensation more closely with shareholder returns.
Miller Austin Scott reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Austin Scott Miller received an equity-linked award of 48 dividend equivalent rights. These rights were granted at a price of $0.00 per right and increase his directly held dividend equivalent rights to 81 following the transaction. According to the disclosure, each dividend equivalent right is economically equal to one common share and accrues on DSU or RSU grants, becoming exercisable in step with the underlying DSUs or RSUs.
SCOTTS MIRACLE-GRO CO director David C. Evans received an equity-related award tied to dividends on prior grants. On March 6, he acquired 105 dividend equivalent rights at a stated price of $0.00 per right. These rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying awards, with each right economically equivalent to one common share. Following this award, Evans directly holds 552 dividend equivalent rights.
Scheiwer Mark J reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro executive Mark J. Scheiwer, EVP, CFO & CAO, reported several equity-related transactions. He received 12.378 shares of phantom stock, each representing the right to one common share or its cash value, and now holds 1,230.699 phantom stock shares.
He was also granted 42 dividend equivalent rights, economically equal to common shares and tied to prior DSU or RSU grants, bringing his total dividend equivalent rights to 405. In a separate transaction coded "J" on common shares, he recorded 2.701 common shares at 55.5400 per share, with direct ownership rising to 15,372.442 shares.
Additionally, he indirectly holds 493.482 common shares through a 401(k) plan. Phantom stock is payable in cash after his employment ends, and he may transfer it into alternative investments at any time.
SCOTTS MIRACLE-GRO CO director Peter E. Shumlin received a grant of 153 Dividend Equivalent Rights on the company’s stock. The award was reported at a price of $0.0000 per right and is classified as a grant or other acquisition. Following this transaction, his directly held Dividend Equivalent Rights total 845. According to the disclosure, these rights accrue on DSU or RSU grants and become exercisable proportionately with the underlying DSUs or RSUs, with each right economically equivalent to one common share.
Aviles Edith reported acquisition or exercise transactions in this Form 4 filing.
Scotts Miracle-Gro director Edith Aviles received a grant of 105 dividend equivalent rights tied to existing equity awards. These derivative rights were awarded at a price of $0.00 per right and increase her directly held derivative position to 552 rights.
The dividend equivalent rights accrue on deferred or restricted stock units and become exercisable proportionately with those underlying units. Each right is described as economically equivalent to one common share of Scotts Miracle-Gro, giving the holder the same cash value as regular share dividends when paid.
Scotts Miracle-Gro president and COO Nathan Eric Baxter reported an administrative change in his holdings of the company’s common shares. The Form 4 lists an “other transaction” involving 90.025 common shares at $55.54 per share, after which his directly held stake is shown as 66,722.4238 common shares.
The filing also updates indirect ownership information. It notes 36,993 common shares held through Hagedorn Partnership, L.P., a Delaware limited partnership where Baxter is a general partner. Under securities rules, he may be deemed a beneficial owner of a proportionate interest in those partnership-held shares.
Kingdon Mark D reported acquisition or exercise transactions in this Form 4 filing.
SCOTTS MIRACLE-GRO CO director Mark D. Kingdon reported an award of 105 Dividend Equivalent Rights on common shares. These rights accrued on DSU or RSU grants at a price of $0.0000 per right, bringing his directly held Dividend Equivalent Rights to 552 following the transaction.
Each Dividend Equivalent Right is the economic equivalent of one common share and becomes exercisable proportionately with the related DSUs or RSUs.
Scotts Miracle-Gro Co director and major shareholder Katherine Littlefield Hagedorn reported an award of derivative securities tied to the company’s common stock. On the reported date, she acquired 33 dividend equivalent rights at a price of $0.00 per right, bringing her holdings of these rights to 33.
According to the disclosure, these dividend equivalent rights accrue on deferred or restricted stock unit grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as being economically equivalent to one common share of Scotts Miracle-Gro.
Scotts Miracle-Gro director Roberto Candelino reported an equity-related award. On March 6, 2026, he acquired 68 dividend equivalent rights at a price of $0.0000 per right, bringing his holdings in these instruments to 218 rights.
The footnote explains that these dividend equivalent rights accrue on DSU or RSU grants and become exercisable in step with the underlying DSUs or RSUs. Each right is described as the economic equivalent of one common share of Scotts Miracle-Gro, aligning the director’s compensation with shareholder outcomes.